Fall35% Off Sitewide

Code…

For laboratory research use only — not for human or veterinary use. Not evaluated by the U.S. FDA.

Bronchogen — studio product photo

Peptide Bioregulator

Bronchogen

Bronchogen BioregulatorBronchi peptide

A short synthetic peptide from the Khavinson bioregulator series, studied in preclinical models for peptide signaling in bronchial and respiratory epithelial tissue.

Quantity

1

$54.99

Bundle & save

What's the reconstitution solution? →

Order by 3:00 PM ET for same-day dispatch

Cutoff 3:00 PM ET · same-day dispatch

Estimated arrival in 2 business days

Overnight shipping available

Free shipment protection included

Free shipping over $150 Secure 256-bit SSL checkout

Bronchogen

1 × 20mg · $54.99

99% purity, QC passed

HPLC + mass-spec verified

Shipment protection

Free on every order

Free shipping over $150

Same-day dispatch before 3PM ET

About Bronchogen

Structure and research context

Bronchogen is a synthetic tetrapeptide from the Khavinson bioregulator series, composed of alanine, glutamic acid, aspartic acid and leucine residues (formula C18H30N4O9, molecular weight 446.5 g/mol, CAS 857267-12-0). As an unmodified short peptide carrying two acidic side chains, it belongs to the group of di- to tetrapeptides this research group has examined for direct interactions with DNA. In the literature it is associated with bronchial epithelial tissue, where it has been examined in cell-culture and rat models.

Bronchogen in the research literature

Biophysical work reported that bronchogen binds double-stranded DNA and raised its melting temperature by about 3.1 °C in differential scanning microcalorimetry, without selectivity for adenine-thymine or guanine-cytosine regions. Fluorescence-quenching studies described preferential binding to CTG-containing deoxyribooligonucleotides.

In cell culture, bronchogen was reported to increase expression of the differentiation factors CXCL12 and Hoxa3 in bronchial epithelial cells, with a more pronounced effect in late-passage cultures. In a rat model of chronic intermittent nitrogen dioxide exposure, studies examined bronchial epithelial morphology, secretory IgA and surfactant protein B levels, and cytokine and cell profiles in bronchoalveolar lavage fluid.

Summarized from peer-reviewed literature for research context only; not a product claim. PubMed: 21240358 · 22117547 · 22808515 · 26468022 · 30199201

Bronchogen Certificate of Analysis

Third-party tested · Independent analytical lab

3 recent lots on file

20mg

99.77%latest

TestedMeasuredPurity
Apr 202622.08mg99.77%
Dec 202524.05mg99.77%
Oct 202524.57mg99.78%

Frequently researched together

Commonly studied alongside Bronchogen.

Compound information

Technical specifications

Molecular profile

TypeSynthetic tetrapeptide bioregulator
CAS number857267-12-0
Molecular weight446.5 g/mol
Amino acids4
SequenceAla-Asp-Glu-Leu
FormulaC18H30N4O9
View on PubChem

Storage & stability

Lyophilized: -20°CReconstituted: 2–8°CProtect from light
  • ❄️

    Lyophilized (powder)

    -20°C · stable 2+ years

  • ❄️

    Reconstituted

    2–8°C · use within 30 days

Bronchogen sources & references

Peer-reviewed literature, for research context

More in Bioregulator

Every Bioregulator research compound in the catalog.

Important research notice

Not for human consumption. This product is sold exclusively for laboratory and in vitro research. It is not intended to diagnose, treat, cure, or prevent any disease.

Any research findings referenced on this page are drawn from published, peer-reviewed literature and are provided for educational context only. They are not product claims and should not be read as medical advice.

By purchasing, you confirm you are a qualified researcher and will handle this material in accordance with all applicable laws and institutional guidelines.